The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years ...

A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study led ...

The FDA has approved Attruby, a new oral treatment that helps reduce heart-related deaths and hospital visits among adults ...

Preclinical studies have shown AT-02 is able to bind to multiple amyloid types and can induce macrophage mediated amyloid phagocytosis and removal. The Food and Drug Administration has granted Orphan ...

Researchers have uncovered how certain genetic mutations lead to unique spherical amyloid plaques in inherited forms of ...

Are you bored of being told that you need to work on your core? Well, you do. But here’s the good news. The best exercise ...

ARIA is the most common side effect of anti–amyloid-beta MAB treatment. MABs increase vascular permeability, which can result in inflammation and leakage of proteinaceous fluid and blood ...

Proteins are essential components of cellular life, uniquely translating genetic information into a vast array of molecular ...

Amyloid fibrils appear in many neurodegenerative ... When the group mutated any of these three amino acids in purified protein experiments, the mutant synucleins packed together much faster ...

Dementia is a debilitating neurodegenerative disease that gradually diminishes life quality, leading to memory loss, ...

A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione ...